Welcome

to AccelLAB
Our new site will be online soon!

Yes!
It’s big News

We are pleased to announce that AccelLAB is resuming its independent turnkey research activities with medical device preclinical safety and efficacy evaluation in Boisbriand, QC, Canada.

Founded in 2004

After some time under the direction of Charles River Laboratories, key members of the management team acquired the group and AccelLAB is bringing back its independent and freestanding contract research organization dedicated to supporting preclinical assessment of medical devices under GLP compliance.
Over the years, your AccelLAB team has demonstrated a leadership role coordinating medical device preclinical services.

More diverse!

Our specialized fields have diversified to include interventional cardiology, orthopedics, dental medicine, spine, neurology, gastroenterology, ENT, sports and regenerative medicine.

More diverse!

Come rediscover our highly specialized services operated and managed by your recognized team:

Study designs from proof of concept to large-scale studies

Surgeries and interventions performed in well-equipped operating suites and catheterization labs

State-of-the-art imaging modalities including C-arm fluoroscopy, high-definition radiography, Micro-CT, MRI and CT-Scan, echocardiography and OCT

On-site necropsy for comprehensive gross examination, tissue harvest and specimen fixation

Routine paraffin and plastic histology with undecalcified bone processing using “Exakt” microgrinding and polishing

Histopathology, histomorphometry, and clinical pathology (hematology and blood biochemistry)

Histopathology reports produced by on-staff veterinary pathologists

Scientific reports produced by study directors and experts in the medical device field

Good Laboratory Practices (GLP) and full Quality Assurance Unit (QAU)

Two (2) successful FDA audits

Two (2) additional accreditations (AAALAC and CCAC)

Welcome back to the same level of commitment to scientific excellence, client-centric appreciation, and understanding of regulatory considerations.

Expect the interaction, dynamism, and cost effectiveness that you have known us for in the past.